The parent's proposed CNY15bn (US$2.2bn) state injection, part of a broader CNY70bn package, underpins the change, though S&P affirmed the reinsurer's 'A-' ratings.
The group combines a technology platform, a BMA-authorised management company and a Class 3 insurer, and updates investors on their insurance investments in near real time.